Cargando…

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats

BACKGROUND: The increasing incidence of obesity and its complications has become a global public health problem. Lingguizhugan decoction (LGZGD) is a representative compound of traditional Chinese medicine (TCM) for metabolic diseases, such as nonalcoholic fatty liver disease, but its role in insuli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Ying, Gong, Yanju, Zheng, Tianyan, Xie, Ya, Yuan, Shiqing, Ding, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375570/ https://www.ncbi.nlm.nih.gov/pubmed/35971521 http://dx.doi.org/10.2147/DMSO.S370492

Ejemplares similares

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
por: Yang, Lili, et al.
Publicado: (2017)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction
por: Li, Baolin, et al.
Publicado: (2021)

Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq
por: Zhu, Mingzhe, et al.
Publicado: (2017)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
por: Cao, Lin, et al.
Publicado: (2022)

Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota
por: Guo, Yi, et al.
Publicado: (2018)

Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Cheng, Ya, et al.
Publicado: (2022)

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
por: Xu, Jingjuan, et al.
Publicado: (2020)

Baogong decoction treats endometritis in mice by regulating uterine microbiota structure and metabolites
por: Ding, He, et al.
Publicado: (2022)

Zhishi Daozhi decoction alleviates constipation induced by a high-fat and high-protein diet via regulating intestinal mucosal microbiota and oxidative stress
por: Peng, Xinxin, et al.
Publicado: (2023)

Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota
por: Zhao, Hongyu, et al.
Publicado: (2022)

Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases
por: Zhang, Mei, et al.
Publicado: (2016)

Intestinal Microbiota and Microbial Metabolites Are Changed in a Pig Model Fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber Diet
por: Heinritz, Sonja N., et al.
Publicado: (2016)

Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation
por: Tan, Rong, et al.
Publicado: (2021)

Modulation of gut microbiota and fecal metabolites by corn silk among high-fat diet-induced hypercholesterolemia mice
por: Ding, Lin, et al.
Publicado: (2022)

Dietary type 2 resistant starch improves systemic inflammation and intestinal permeability by modulating microbiota and metabolites in aged mice on high-fat diet
por: Zhang, Yawen, et al.
Publicado: (2020)

Can Diet Influence Our Health by Altering Intestinal Microbiota-Derived Fecal Metabolites?
por: Lyu, Qiang, et al.
Publicado: (2018)

Intestinal Microbiota-Associated Metabolites: Crucial Factors in the Effectiveness of Herbal Medicines and Diet Therapies
por: Wang, Yiliang, et al.
Publicado: (2019)

Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet
por: Bi, Chao-Ran, et al.
Publicado: (2023)

Sanguinarine Improves Intestinal Health in Grass Carp Fed High-Fat Diets: Involvement of Antioxidant, Physical and Immune Barrier, and Intestinal Microbiota
por: Shi, Yong, et al.
Publicado: (2023)

Dahuang Zexie Decoction Protects against High-Fat Diet-Induced NAFLD by Modulating Gut Microbiota-Mediated Toll-Like Receptor 4 Signaling Activation and Loss of Intestinal Barrier
por: Fang, Jing, et al.
Publicado: (2017)

Whole Grain Qingke Attenuates High-Fat Diet-Induced Obesity in Mice With Alterations in Gut Microbiota and Metabolite Profile
por: Li, Xipu, et al.
Publicado: (2021)

Qingchang Wenzhong Decoction Prevents the Occurrence of Intestinal Tumors by Regulating Intestinal Microbiota and Gasdermin E
por: Ren, Lingli, et al.
Publicado: (2022)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats
por: Hang, Lu, et al.
Publicado: (2022)

Alteration and the Function of Intestinal Microbiota in High-Fat-Diet- or Genetics-Induced Lipid Accumulation
por: Qiao, Fang, et al.
Publicado: (2021)

High-fat diet impact on intestinal cholesterol conversion by the microbiota and serum cholesterol levels
por: Bubeck, Alena M., et al.
Publicado: (2023)

Kun-Dan Decoction Ameliorates Insulin Resistance by Activating AMPK/mTOR-Mediated Autophagy in High-Fat Diet-Fed Rats
por: Su, Zuqing, et al.
Publicado: (2021)

Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
por: Zhang, Xiao-Yu, et al.
Publicado: (2020)

Baohe pill decoction treats diarrhea induced by high-fat and high-protein diet by regulating lactase-producing bacteria in intestinal mucosa
por: Zhou, Kang, et al.
Publicado: (2023)

Jia-Wei-Si-Miao-Yong-An decoction modulates intestinal flora and metabolites in acute coronary syndrome model
por: Zhao, Ning, et al.
Publicado: (2023)

Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet
por: Tamura, Motoi, et al.
Publicado: (2019)

Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota
por: Zhong, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cqn5ab874egbelc3ne1t4fp9sp